Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1990-05-22
1992-12-15
Ramsuer, Robert W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514394, 548101, 548252, 548254, 5483107, 5483044, A61K 3141, A61K 31415, C07D25704, C07D23508
Patent
active
051717484
ABSTRACT:
The invention concerns novel heterocyclic compounds of the formula I as defined herein and their physiologically acceptable salts, together with pharmaceutical compositions containing them. The heterocyclic compounds antagonize the actions of angiotensin II and are of value in treating diseases or medical conditions such as hypertension and congestive heart failure in warm-blooded animals. The invention further includes processes for the manufacture of the novel compounds and their use in medical treatment.
REFERENCES:
patent: 4612323 (1986-09-01), Kisida et al.
patent: 4663339 (1987-05-01), Kisida et al.
patent: 4820843 (1989-04-01), Aldrich et al.
patent: 4859692 (1989-08-01), Bernstein et al.
patent: 4870186 (1989-09-01), Aldrich et al.
patent: 4874867 (1989-10-01), Aldrich et al.
patent: 4880804 (1989-11-01), Carini et al.
patent: 5051530 (1991-09-01), Chang et al.
Sinkula, A. A. "Prodrug Approach in Drug Design" In Ann. Rep. Med. Chem. (1975), 10, 306-316.
Stella, V. "Pro-drugs: An Overview and Definition" and Sinkula, A. A. "Application of the Pro-drug Approach to Antibiotics" In Pro-Drugs as Novel Drug Delivery Systems; Higuchi, T. and Stella V. Eds.; ACS Symposium Series 14, American Chemical Society: Washington, DC, 1975; pp. 1-15, 44-45, 116-153.
Bundgaard, H. "Design of prodrugs: Bioreversible derivatives for various functional groups and chemical entities" In Design of Prodrugs; Bundgaard, H., Ed.; Elsevier Science Publishers: Amsterdam, 1985; pp. 1-10.
Bundgaard, H., "Design of Bioreversible Drug Derivatives and the Utility of the Double Prodrug Concept" In Bioreversible Carriers in Drug Design; Roche, E. B., Ed.; Pergamon Press: New York, 1987; pp. 13-21.
Roberts David A.
Russell Simon T.
Ambrose Michael G.
Imperial Chemical Industries plc
Jackson Thomas E.
Ramsuer Robert W.
LandOfFree
Benz[4,5]imidazole-containing angiotensin antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Benz[4,5]imidazole-containing angiotensin antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Benz[4,5]imidazole-containing angiotensin antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2093073